0001209191-20-035110.txt : 20200608 0001209191-20-035110.hdr.sgml : 20200608 20200608185947 ACCESSION NUMBER: 0001209191-20-035110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191001 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Muller Lorenz CENTRAL INDEX KEY: 0001771207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38899 FILM NUMBER: 20950463 MAIL ADDRESS: STREET 1: C/O MILESTONE PHARMACEUTICALS, INC. STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001408443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 BUSINESS PHONE: (514) 336-0444 MAIL ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-01 0 0001408443 Milestone Pharmaceuticals Inc. MIST 0001771207 Muller Lorenz C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 MONTR?AL A8 H4M 2X6 QUEBEC, CANADA 0 1 0 0 Chief Commercial Officer Common Shares 2019-10-01 4 M 0 2500 1.54 A 52115 D Common Shares 2020-04-03 4 M 0 32528 1.54 A 84643 D Common Shares 2020-04-03 4 M 0 18043 1.54 A 102686 D Employee Stock Option (right to buy) 1.54 2019-10-01 4 M 0 2500 0.00 D 2027-10-11 Common Shares 2500 87982 D Employee Stock Option (right to buy) 1.54 2020-04-03 4 M 0 32528 0.00 D 2027-10-11 Common Shares 32528 55454 D Employee Stock Option (right to buy) 1.54 2020-04-03 4 M 0 18043 0.00 D 2028-10-15 Common Shares 18043 32903 D Employee Stock Option (right to buy) 3.74 2020-06-05 4 A 0 35000 0.00 A 2030-06-05 Common Shares 35000 35000 D The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. The original grant was for 50,946 option shares. Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date. /s/ Eric Popp, Attorney-in-Fact 2020-06-08